| Literature DB >> 22726420 |
Mariluz Arainga1, Hironobu Murakami, Yoko Aida.
Abstract
BACKGROUND: Human T cell leukemia virus type 1 (HTLV-1) Tax is a potent activator of viral and cellular gene expression that interacts with a number of cellular proteins. Many reports show that Tax is capable of regulating cell cycle progression and apoptosis both positively and negatively. However, it still remains to understand why the Tax oncoprotein induces cell cycle arrest and apoptosis, or whether Tax-induced apoptosis is dependent upon its ability to induce G1 arrest. The present study used time-lapse imaging to explore the spatiotemporal patterns of cell cycle dynamics in Tax-expressing HeLa cells containing the fluorescent ubiquitination-based cell cycle indicator, Fucci2. A large-scale host cell gene profiling approach was also used to identify the genes involved in Tax-mediated cell signaling events related to cellular proliferation and apoptosis.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22726420 PMCID: PMC3537563 DOI: 10.1186/1471-2164-13-275
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Tax induces Gcell cycle arrest and apoptosis. HeLa cells were transiently transfected with a pCAGGS-Tax Flag-tagged vector or the control pCAGGS vector (A, B and E) together with either the reporter plasmid pGV-HL21 (HTLV-1 enhancer) and the reference plasmid pRL-SV40 (C), or the GFP expression vector pEGFP-NI (D and G) or the pSV-β-galactosidase vector (F). (A) At 24 h post-transfection, cells were lysed and subjected to immunoblot analysis with an anti-Flag MAb and an anti-actin MAb (as a control). (B) At 24 h post-transfection, cells were fixed, permeabilized, and immunostained with an anti-Flag MAb followed by an Alexa 488-conjugated anti-mouse IgG antibody. Cells were analyzed by confocal laser scanning microscopy (Olympus FV1000). (C) At 48 h after transfection, cells were recovered and the activities of firefly and Renilla luciferases were measured in lysates. For each sample, the firefly luciferase activity (pGV-HL21) was normalized by reference to Renilla luciferase activity (pRL-SV40). (D) At 48 h post-transfection, cells were fixed and stained with propidium iodide for the analysis of DNA content. GFP-positive cells were analyzed by flow cytometry using Cell Quest for acquisition and ModFit LT. The peaks of the cells at G1 and G2/M phase are indicated. (E) At 48 h post-transfection, cells were collected, lysed, and analyzed for phosphorylation of Rb by immunoblotting with an anti-Rb MAb using an anti-actin MAb as a control. ppRb, hyperphosphorylated forms of Rb; pRb, hypo- and unphosphorylated forms of Rb. (F) At 48 h post-transfection, cells were collected, lysed, β-galactosidase activity was measured. Caspase-3 activity was measured in the cell lysates with an equal amount of β-galactosidase activity. Each of the columns and its associated error bar represent the mean ± standard deviation (SD) of results from four different experiments. The asterisk (*) represents a p-value of < 0.01. (G) At 48 h post-transfection, cells were stained with PE-Annexin V and 7-AAD to identify apoptotic cells. GFP was used as a reporter to discriminate between transfected and untransfected cells. The percentage of Annexin V-positive and 7-AAD-negative cells relative to GFP-positive cells indicates the level of apoptosis.
Genes upregulated by Tax (fold change ≥ 2.0, p < 0.05)
| | | | |
| FOXF1 | forkhead box F1 | 2294 | 2.0 |
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 4791 | 2.0 |
| NR6A1 | nuclear receptor subfamily 6, group A, member 1 | 2649 | 2.0 |
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 1052 | 2.1 |
| ETV5 | ets variant 5 | 2119 | 2.1 |
| FST | follistatin | 10468 | 2.2 |
| KLF6 | Kruppel-like factor 6 | 1316 | 2.2 |
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 1052 | 2.3 |
| EGR3 | early growth response 3 | 1960 | 2.3 |
| SAMD4A | sterile alpha motif domain containing 4A | 23034 | 2.3 |
| ELL2 | elongation factor, RNA polymerase II, 2 | 22936 | 2.4 |
| HIVEP2 | human immunodeficiency virus type I enhancer binding protein 2 | 3097 | 2.4 |
| MAFB | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | 9935 | 2.4 |
| FOSL2 | FOS-like antigen 2 | 2355 | 2.5 |
| ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 3398 | 2.5 |
| KLF2 | Kruppel-like factor 2 (lung) | 10365 | 2.5 |
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 5971 | 2.5 |
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 23764 | 2.8 |
| LARP6 | La ribonucleoprotein domain family, member 6 | 55323 | 3.1 |
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 5966 | 3.1 |
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 2354 | 3.2 |
| HES1 | hairy and enhancer of split 1 (Drosophila) | 3280 | 3.2 |
| SOD2 | superoxide dismutase 2, mitochondrial | 6648 | 3.4 |
| ATF3 | activating transcription factor 3 | 467 | 3.6 |
| FOSL1 | FOS-like antigen 1 | 8061 | 4.1 |
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 7538 | 4.2 |
| ZNF331 | zinc finger protein 331 | 55422 | 4.4 |
| BACH2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 | 60468 | 4.4 |
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 4794 | 4.4 |
| EGR1 | early growth response 1 | 1958 | 6.2 |
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 2353 | 8.4 |
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 4929 | 10.9 |
| | | | |
| EDN2 | endothelin 2 | 1907 | 2.0 |
| EPHA2 | EPH receptor A2 | 1969 | 2.1 |
| RIT1 | Ras-like without CAAX 1 | 6016 | 2.1 |
| SH2D3A | SH2 domain containing 3A | 10045 | 2.1 |
| KLRC1 | killer cell lectin-like receptor subfamily C, member 1///killer cell lectin-like receptor subfamily C, member 2 | 3821 | 2.2 |
| PSD4 | pleckstrin and Sec7 domain containing 4 | 23550 | 2.5 |
| ADM | adrenomedullin | 133 | 2.7 |
| GPRC5C | G-protein-coupled receptor, family C, group 5, member C | 55890 | 2.7 |
| BDKRB2 | bradykinin receptor B2 | 624 | 2.8 |
| GDF15 | growth differentiation factor 15 | 9518 | 3.0 |
| GPR87 | G protein-coupled receptor 87 | 53836 | 3.4 |
| RASA4 | RAS p21 protein activator 4///RAS p21 protein activator 4 pseudogene | 10156 | 8.8 |
| GEM | GTP binding protein overexpressed in skeletal muscle | 2669 | 14.1 |
| GABBR1 | gamma-aminobutyric acid (GABA) B receptor, 1///ubiquitin D | 10537 | 24.5 |
| RRAD | Ras-related associated with diabetes | 6236 | 115.2 |
| | | | |
| KLRC1 | killer cell lectin-like receptor subfamily C, member 1 | 3821 | 2.2 |
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 5743 | 2.3 |
| CCL22 | chemokine (C-C motif) ligand 22 | 6367 | 3.0 |
| IL6R | interleukin 6 receptor | 3570 | 3.0 |
| TNIP1 | TNFAIP3 interacting protein 1 | 10318 | 3.2 |
| EBI3 | Epstein-Barr virus induced 3 | 10148 | 3.2 |
| IL27RA | interleukin 27 receptor, alpha | 9466 | 3.5 |
| TRIM22 | tripartite motif-containing 22 | 10346 | 3.8 |
| IL32 | interleukin 32 | 9235 | 3.8 |
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 7130 | 4.0 |
| GBP2 | guanylate binding protein 2, interferon-inducible | 2634 | 5.2 |
| GBP2 | guanylate binding protein 2, interferon-inducible | 2634 | 5.4 |
| CCL19 | chemokine (C-C motif) ligand 19 | 6363 | 6.2 |
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 2919 | 11.7 |
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 6373 | 13.1 |
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 2921 | 19.1 |
| CCL20 | chemokine (C-C motif) ligand 20 | 6364 | 20.1 |
| PTX3 | pentraxin-related gene, rapidly induced by IL-1 beta | 5806 | 81.1 |
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 2920 | 87.0 |
| | | | |
| ZMAT3 | zinc finger, matrin type 3 | 64393 | 2.0 |
| JMJD6 | jumonji domain containing 6 | 23210 | 2.0 |
| AEN | apoptosis enhancing nuclease | 64782 | 2.1 |
| ADORA2A | adenosine A2a receptor | 135 | 2.2 |
| CD70 | CD70 molecule | 970 | 2.2 |
| FAS | Fas (TNF receptor superfamily, member 6) | 355 | 2.3 |
| BAG3 | BCL2-associated athanogene 3 | 9531 | 2.4 |
| BIK | BCL2-interacting killer (apoptosis-inducing) | 638 | 2.4 |
| BCL6 | B-cell CLL/lymphoma 6 | 604 | 2.7 |
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 7133 | 3.3 |
| ZC3H12A | zinc finger CCCH-type containing 12A | 80149 | 4.1 |
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 4792 | 5.2 |
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 3164 | 5.4 |
| IER3 | immediate early response 3 | 8870 | 5.7 |
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 7128 | 6.4 |
| BTG2 | BTG family, member 2 | 7832 | 7.0 |
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 3604 | 8.2 |
| BIRC3 | baculoviral IAP repeat-containing 3 | 330 | 14.8 |
| IL6 | interleukin 6 (interferon, beta 2) | 3569 | 18.0 |
| | | | |
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 1647 | 2.2 |
| RGS2 | regulator of G-protein signaling 2, 24 kDa | 5997 | 2.2 |
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 1326 | 2.3 |
| SESN1 | sestrin 1 | 27244 | 2.6 |
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 1026 | 2.8 |
| CYLD | cylindromatosis (turban tumor syndrome) | 1540 | 2.9 |
| PLK2 | polo-like kinase 2 (Drosophila) | 10769 | 3.0 |
| SMAD3 | SMAD family member 3 | 4088 | 4.4 |
| JUN | jun oncogene | 3725 | 4.6 |
| GADD45B | growth arrest and DNA-damage-inducible, beta | 4616 | 4.8 |
| DUSP1 | dual specificity phosphatase 1 | 1843 | 8.5 |
| IL8 | interleukin 8 | 3576 | 41.7 |
| | | | |
| ZMAT3 | zinc finger, matrin type 3 | 64393 | 2.0 |
| CSF1 | colony stimulating factor 1 (macrophage) | 1435 | 2.1 |
| FGFR2 | fibroblast growth factor receptor 2 | 2263 | 2.1 |
| ABTB2 | ankyrin repeat and BTB (POZ) domain containing 2 | 25841 | 2.4 |
| SOCS2 | suppressor of cytokine signaling 2 | 8835 | 2.4 |
| PGF | placental growth factor | 5228 | 2.6 |
| HBEGF | heparin-binding EGF-like growth factor | 1839 | 2.7 |
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 3976 | 2.9 |
| FGF18 | fibroblast growth factor 18 | 8817 | 4.9 |
| CCL2 | chemokine (C-C motif) ligand 2 | 6347 | 6.7 |
| IL11 | interleukin 11 | 3589 | 7.4 |
| RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 5918 | 7.5 |
| IGFBP1 | insulin-like growth factor binding protein 1 | 3484 | 32.2 |
| DLGAP4 | discs, large (Drosophila) homolog-associated protein 4 | 22839 | 2.5 |
| EFNA1 | ephrin-A1 | 1942 | 2.5 |
| WNT4 | wingless-type MMTV integration site family, member 4 | 54361 | 9.3 |
| | | | |
| LYPD3 | LY6/PLAUR domain containing 3 | 27076 | 2.0 |
| PDZD2 | PDZ domain containing 2 | 23037 | 2.1 |
| FERMT2 | fermitin family homolog 2 (Drosophila) | 10979 | 2.2 |
| NINJ1 | ninjurin 1 | 4814 | 2.2 |
| SIRPA | signal-regulatory protein alpha | 140885 | 2.2 |
| COL7A1 | collagen, type VII, alpha 1 | 1294 | 2.3 |
| LAMB3 | laminin, beta 3 | 3914 | 2.6 |
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 1003 | 4.4 |
| CTGF | connective tissue growth factor | 1490 | 4.4 |
| SAA1 | serum amyloid A1///serum amyloid A2 | 6288 | 10.3 |
| ICAM1 | intercellular adhesion molecule 1 | 3383 | 10.8 |
| | | | |
| SLC37A1 | solute carrier family 37 (glycerol-3-phosphate transporter), member 1 | 54020 | 2.0 |
| SLC1A3 | solute carrier family 1 (glial high affinity glutamate transporter), member 3 | 6507 | 2.2 |
| C19orf28 | chromosome 19 open reading frame 28 | 126321 | 2.6 |
| NPTX1 | neuronal pentraxin I | 4884 | 2.6 |
| SLC2A6 | solute carrier family 2 (facilitated glucose transporter), member 6 | 11182 | 3.5 |
| HBA1 | hemoglobin, alpha 1 | 3039 | 5.4 |
| | | | |
| HMGCS1 | 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble) | 3157 | 2.0 |
| PTGS1 | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | 5742 | 2.0 |
| IDS | iduronate 2-sulfatase | 3423 | 2.2 |
| PI4K2A | phosphatidylinositol 4-kinase type 2 alpha | 55361 | 2.2 |
| PLA2G4C | phospholipase A2, group IVC (cytosolic, calcium-independent) | 8605 | 2.2 |
| C12orf5 | chromosome 12 open reading frame 5 | 57103 | 2.3 |
| PANX1 | pannexin 1 | 24145 | 2.3 |
| ABCA1 | ATP-binding cassette, subfamily A (ABC1), member 1 | 19 | 2.4 |
| AMPD3 | adenosine monophosphate deaminase (isoform E) | 272 | 2.4 |
| SAT1 | spermidine/spermine N1-acetyltransferase 1 | 6303 | 2.5 |
| AKR1B1 | aldo-keto reductase family 1, member B1 (aldose reductase) | 231 | 2.6 |
| GCNT3 | glucosaminyl (N-acetyl) transferase 3, mucin type | 9245 | 2.6 |
| PITPNM1 | phosphatidylinositol transfer protein, membrane-associated 1 | 9600 | 2.6 |
| MICAL2 | microtubule-associated monoxygenase, calponin and LIM domain containing 2 | 9645 | 3.2 |
| PPAP2B | phosphatidic acid phosphatase type 2B | 8613 | 3.2 |
| ARG2 | arginase, type II | 384 | 4.1 |
| PTGES | prostaglandin E synthase | 9536 | 4.7 |
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 9945 | 5.0 |
| | | | |
| DUSP6 | dual specificity phosphatase 6 | 1848 | 2.0 |
| FAM129A | family with sequence similarity 129, member A | 116496 | 2.3 |
| DUSP13 | dual specificity phosphatase 13 | 51207 | 2.6 |
| DUSP5 | dual specificity phosphatase 5 | 1847 | 4.1 |
| PTPRE | protein tyrosine phosphatase, receptor type, E | 5791 | 4.1 |
| | | | |
| HSPA2 | heat shock 70 kDa protein 2 | 3306 | 2.3 |
| HSPA1A | heat shock 70 kDa protein 1A | 3303 | 2.9 |
| HSPB8 | heat shock 22 kDa protein 8 | 26353 | 3.1 |
| HSPB3 | heat shock 27 kDa protein 3 | 8988 | 4.0 |
| HSPB7 | heat shock 27 kDa protein family, member 7 (cardiovascular) | 27129 | 4.0 |
| DNAJB1 | DnaJ (Hsp40) homolog, subfamily B, member 1 | 3337 | 4.2 |
| HSPA6 | heat shock 70 kDa protein 6 | 3310 | 7.6 |
| | | | |
| ENC1 | ectodermal-neural cortex (with BTB-like domain) | 8507 | 2.3 |
| MAP1LC3C | microtubule-associated protein 1 light chain 3 gamma | 440738 | 3.4 |
| | | | |
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 4973 | 2.0 |
| TRIB1 | tribbles homolog 1 (Drosophila) | 10221 | 2.0 |
| UNC13A | unc-13 homolog A (C. elegans) | 23025 | 2.0 |
| SNAI1 | snail homolog 1 (Drosophila) | 6615 | 2.1 |
| FSTL3 | follistatin-like 3 (secreted glycoprotein) | 10272 | 2.2 |
| GAB2 | GRB2-associated binding protein 2 | 9846 | 2.2 |
| PDLIM3 | PDZ and LIM domain 3 | 27295 | 2.2 |
| PMEPA1 | prostate transmembrane protein, androgen induced 1 | 56937 | 2.2 |
| SLC1A3 | solute carrier family 1 (glial high affinity glutamate transporter), member 3 | 6507 | 2.2 |
| FNDC3B | fibronectin type III domain containing 3B | 64778 | 2.3 |
| PHLDA3 | pleckstrin homology-like domain, family A, member 3 | 23612 | 2.3 |
| SLC25A4 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 | 291 | 2.3 |
| TPM4 | tropomyosin 4 | 7171 | 2.3 |
| DSE | dermatan sulfate epimerase | 29940 | 2.5 |
| VEGFC | vascular endothelial growth factor C | 7424 | 2.5 |
| CSTA | cystatin A (stefin A) | 1475 | 2.6 |
| ZDHHC18 | zinc finger, DHHC-type containing 18 | 84243 | 2.6 |
| CDK2AP2 | cyclin-dependent kinase 2 associated protein 2 | 10263 | 2.7 |
| TIPARP | TCDD-inducible poly(ADP-ribose) polymerase | 25976 | 2.7 |
| CSTA | cystatin A (stefin A) | 1475 | 2.8 |
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 7127 | 2.8 |
| PSD4 | pleckstrin and Sec7 domain containing 4 | 23550 | 3.1 |
| KRT17 | keratin 17 | 3872 | 3.7 |
| ARC | activity-regulated cytoskeleton-associated protein | 23237 | 5.4 |
| LXN | latexin | 56925 | 5.5 |
| TRIM31 | tripartite motif-containing 31 | 11074 | 20.1 |
Genes downregulated by Tax (fold change ≥ 2.0, p < 0.05)
| | | | |
| ANP32A | Cerebellar leucine rich acidic nuclear protein (LANP) | 8125 | 2.0 |
| EID1 | EP300 interacting inhibitor of differentiation 1 | 23741 | 2.0 |
| PAIP1 | poly(A) binding protein interacting protein 1 | 10605 | 2.0 |
| RBM4 | RNA binding motif protein 4 | 5936 | 2.0 |
| SFRS7 | splicing factor, arginine/serine-rich 7, 35 kDa | 6432 | 2.0 |
| SR140 | U2-associated SR140 protein | 23350 | 2.0 |
| BCLAF1 | BCL2-associated transcription factor 1 | 9774 | 2.1 |
| IMPACT | Impact homolog (mouse) | 55364 | 2.3 |
| LSM5 | LSM5 homolog, U6 small nuclear RNA associated (S. cerevisiae) | 23658 | 2.3 |
| MRPS14 | mitochondrial ribosomal protein S14 | 63931 | 2.3 |
| SUB1 | SUB1 homolog (S. cerevisiae) | 10923 | 2.3 |
| ZNF623 | zinc finger protein 623 | 9831 | 2.3 |
| BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | 83990 | 2.4 |
| TTF2 | transcription termination factor, RNA polymerase II | 8458 | 2.6 |
| | | | |
| PDE1A | phosphodiesterase 1A, calmodulin-dependent | 5136 | 2.0 |
| PDE3A | phosphodiesterase 3A, cGMP-inhibited | 5139 | 2.0 |
| PRKCI | protein kinase C, iota | 5584 | 2.1 |
| SRI | sorcin | 6717 | 2.8 |
| | | | |
| DDX58 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | 23586 | 2.2 |
| IFI44 | interferon-induced protein 44 | 10561 | 2.2 |
| DDX60 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 | 55601 | 3.0 |
| IFIT3 | interferon-induced protein with tetratricopeptide repeats 3 | 3437 | 4.1 |
| IFIT2 | interferon-induced protein with tetratricopeptide repeats 2 | 3433 | 4.4 |
| IFIT1 | interferon-induced protein with tetratricopeptide repeats 1 | 3434 | 6.0 |
| OASL | 2'-5'-oligoadenylate synthetase-like | 8638 | 6.4 |
| | | | |
| CARD10 | caspase recruitment domain family, member 10 | 29775 | 2.0 |
| BCLAF1 | BCL2-associated transcription factor 1 | 9774 | 2.1 |
| | | | |
| MAD2L1 | MAD2 mitotic arrest deficient-like 1 (yeast) | 4085 | 2.0 |
| KIF11 | kinesin family member 11 | 3832 | 2.1 |
| NF2 | neurofibromin 2 (merlin) | 4771 | 2.1 |
| SEP11 | septin 11 | 55752 | 2.1 |
| CENPF | centromere protein F, 350/400 ka (mitosin) | 1063 | 2.5 |
| | | | |
| BMP2 | bone morphogenetic protein 2 | 650 | 2.2 |
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 1601 | 2.4 |
| FGF2 | fibroblast growth factor 2 (basic) | 2247 | 3.4 |
| | | | |
| PCSK1 | proprotein convertase subtilisin/kexin type 1 | 5122 | 4.8 |
| | | | |
| CD24 | CD24 molecule | 100133941 | 2.3 |
| PKP2 | plakophilin 2 | 5318 | 2.3 |
| COL14A1 | collagen, type XIV, alpha 1 | 7373 | 2.5 |
| | | | |
| H2AFV | H2A histone family, member V | 94239 | 2.0 |
| | | | |
| CNGB1 | cyclic nucleotide gated channel beta 1 | 1258 | 2.0 |
| SCNN1A | sodium channel, nonvoltage-gated 1 alpha | 6337 | 2.0 |
| ANO2 | anoctamin 2 | 57101 | 2.1 |
| CHRNA9 | cholinergic receptor, nicotinic, alpha 9 | 55584 | 2.2 |
| SORBS1 | sorbin and SH3 domain containing 1 | 10580 | 2.3 |
| STEAP4 | STEAP family member 4 | 79689 | 2.3 |
| SRI | sorcin | 6717 | 2.6 |
| | | | |
| ACSL4 | acyl-CoA synthetase long-chain family member 4 | 2182 | 2.0 |
| | | | |
| FBXO3 | F-box protein 3 | 26273 | 2.0 |
| HERC6 | hect domain and RLD 6 | 55008 | 2.1 |
| DZIP3 | DAZ interacting protein 3, zinc finger | 9666 | 2.3 |
| HERC5 | hect domain and RLD 5 | 51191 | 4.8 |
| | | | |
| NIP7 | nuclear import 7 homolog (S. cerevisiae) | 51388 | 2.0 |
| PPL | periplakin | 5493 | 2.0 |
| ADK | adenosine kinase | 132 | 2.1 |
| DIO2 | deiodinase, iodothyronine, type II | 1734 | 2.1 |
| PICALM | phosphatidylinositol binding clathrin assembly protein | 8301 | 2.1 |
| METAP2 | methionyl aminopeptidase 2 | 10988 | 2.2 |
| HIP1R | huntingtin interacting protein 1 related | 9026 | 2.3 |
| ERAP1 | KIAA0525 protein | 51752 | 2.4 |
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 1601 | 2.5 |
Figure 2Expression profile of genes involved in cell cycle regulation and apoptosis that were altered following the induction of Tax protein. Heat maps showing the hierarchical clustering of genes involved in cell cycle regulation (A) and apoptosis (C) are shown for Tax-expressing cells. The color scheme indicates the fold change in gene expression, with upregulated genes shown in orange/red and downregulated genes shown in blue (with respect to baseline levels under control conditions (yellow)). qRT-PCR validation of the upregulated genes associated with cell cycle regulation (B) and apoptosis (D). RNA from Tax-expressing cells and control cells was used to validate the microarray data. The bars indicate the fold change in gene expression following Tax expression. Data were normalized to GAPDH mRNA. The results represent the mean of two samples from one experiment
Figure 3Time-lapse imaging of morphological changes in HeLa/Fucci2 cells after Tax-induced cell cycle arrest at Gphase. (A) HeLa cells were transfected with the pCAGGS-Tax-IRES-CFP vector or the control pCAGGS-IRES-CFP vector. At 24 h after transfection, cells were stained with an anti-Flag MAb followed by an Alexa Fluor 594-conjugated secondary MAb and analyzed by confocal laser scanning microscopy (Olympus FV1000). Cells showing red and blue fluorescence express Tax-Flag and CFP, respectively. (B and C) HeLa/Fucci2 cells were transfected with the CAGGS-Tax-IRES-CFP vector or the control pCAGGS-IRES-CFP vector and monitored by time-lapse photography using the Olympus LCV110 Imaging System. One day after transfection, CFP-positive cells were selected and fluorescence and phase images were captured once every 15 min for 2 days. Cells showing orange or green fluorescence are in the G1 or S/G2/M phase of cell cycle, respectively. Apoptotic cells, which show a rounded morphology, are marked by arrows. The populations of CFP-expressing cells at the G1 and S/G2/M phases (D and E, respectively) were quantified using MetaMorph 7.7.4 software
Figure 4Expression kinetics of genes involved in cell cycle regulation and apoptosis that were altered following induction of Tax. HeLa cells were transiently transfected with a pCAGGS-Tax Flag-tagged vector or the control pCAGGS vector. Total RNA was prepared at 12, 24, 36 and 48 h after transfection and then each RNA sample was subjected to qRT-PCR. The bars indicate the fold change in the gene following Tax expression. Data were normalized to GAPDH mRNA. The results represent the mean ± standard deviation (SD) of three samples from one experiment